Research Grand Rounds: An Alternative to Target-Based Drug Discovery-Optimizing Mitochondrial Bioenergetics to Combat Noncommunicable Diseases—November 6, 2020

Research Grand Rounds: An Alternative to Target-Based Drug Discovery-Optimizing Mitochondrial Bioenergetics to Combat Noncommunicable Diseases—November 6, 2020

Share this

Research Grand Rounds are sponsored by the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) and MedStar Health Research Institute to bring together our diverse clinical and research communities to share research that spans disciplines and stages of translation to improve individual and community health.

On behalf of the Georgetown-Howard Universities Center for Clinical and Translational Science, and MedStar Health Research Institute, you are invited to Clinical and Translational Research Grand Rounds on Friday, November 6, 2020 from 12:00pm to 1:00pm. The speaker this month will be Hazel H. Szeto, MD, PhD who will discuss “An alternative to target-based drug discovery-Optimizing mitochondrial bioenergetics to combat noncommunicable diseases”.

Live Stream Link: https://georgetown.zoom.us/j/527229623

Dr. Szeto is director of research at the Social Profit Network Research Laboratory, professor emerita of Pharmacology at Weill Medical College of Cornell University, and scientific founder of Stealth Biotherapeutics. Her serendipitous discovery of a novel class of orally-active, widely-distributed mitochondrial-targeted peptide analogs with profound effects on mitochondrial structure and function has revealed bioenergetic mechanisms as key treatment targets in an almost-dizzying variety of disease models. Preclinical models suggest potential

benefits in most all clinical domains, from ischemia-reperfusion injury to neurodegeneration, and including heart failure, muscle weakness and disuse atrophy, chemotherapy toxicities, diabetes, vision loss, orthopedic injury, acute kidney injury and progressive chronic kidney disease and a wide range of age-associated chronic diseases. Her research exemplifies widely collaborative and discipline-spanning team science focused on translating basic discoveries to therapeutic impact while revealing new pathophysiological mechanisms and basic biology.

Research Grand Rounds are open to all members of the research team, from principal investigators to clinical and research coordinators and trainees. Topics covered in the Research Grand Rounds range from community-focused research to best practices and are intended to increase collaboration within the research community in and outside of MedStar Health.

For more information please contact research@medstar.net or visit www.georgetownhowardctsa.org

Stay up to date and subscribe to our blog

Latest blogs